| Mrs Pamela D Mcgarrah, MD | |
|
1100 S Jackson Hwy Ste 250, Sheffield, AL 35660-5774 | |
| (256) 381-6673 | |
| (256) 381-8091 |
| Full Name | Mrs Pamela D Mcgarrah |
|---|---|
| Gender | Female |
| Speciality | Otolaryngology |
| Experience | 33 Years |
| Location | 1100 S Jackson Hwy Ste 250, Sheffield, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407957129 | NPI | - | NPPES |
| 140226001 | Medicaid | AR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | MD.36409 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Helen Keller Hospital | Sheffield, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nw Alabama Practice Management, Llc | 1951434539 | 15 |
News Archive
Taking turns gazing into a surgical microscope, 130 seventh- and eighth-graders from Los Angeles area schools will see a phantom skull and perform virtual surgery - and many could catch a glimpse of the future.
The Alzheimer's Drug Discovery Foundation (ADDF) announced today that it has awarded a grant of $240,000 to AgeneBio Inc. to develop a new class of small-molecules that have promise in treating amnestic mild cognitive impairment (aMCI), a neurological condition that often progresses to Alzheimer's disease and affects more than 3 million aging Americans.
"The number of Americans enrolled in high-deductible health plans has risen to more than 10 million but still represents a small portion of the insurance market, according to a report from insurance group America's Health Insurance Plans. Enrollments in these high-deductible health plans, which typically are paired with tax-free health savings accounts or health-reimbursement arrangements, are up about 25 percent from last year, the report said" (5/20).
The U.S. Food and Drug Administration today approved several strengths of potassium chloride oral solution as the first generic drugs to receive a Competitive Generic Therapy designation.
MINDBODY, Inc., the industry leader in cloud-based, business management software for health and wellness organizations worldwide, has received a major investment from two of the country's most respected venture capital firms, Bessemer Venture Partners and Catalyst Investors.
› Verified 8 days ago
| Entity Name | Nw Alabama Practice Management, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083937452 PECOS PAC ID: 1951434539 Enrollment ID: O20100803000717 |
News Archive
Taking turns gazing into a surgical microscope, 130 seventh- and eighth-graders from Los Angeles area schools will see a phantom skull and perform virtual surgery - and many could catch a glimpse of the future.
The Alzheimer's Drug Discovery Foundation (ADDF) announced today that it has awarded a grant of $240,000 to AgeneBio Inc. to develop a new class of small-molecules that have promise in treating amnestic mild cognitive impairment (aMCI), a neurological condition that often progresses to Alzheimer's disease and affects more than 3 million aging Americans.
"The number of Americans enrolled in high-deductible health plans has risen to more than 10 million but still represents a small portion of the insurance market, according to a report from insurance group America's Health Insurance Plans. Enrollments in these high-deductible health plans, which typically are paired with tax-free health savings accounts or health-reimbursement arrangements, are up about 25 percent from last year, the report said" (5/20).
The U.S. Food and Drug Administration today approved several strengths of potassium chloride oral solution as the first generic drugs to receive a Competitive Generic Therapy designation.
MINDBODY, Inc., the industry leader in cloud-based, business management software for health and wellness organizations worldwide, has received a major investment from two of the country's most respected venture capital firms, Bessemer Venture Partners and Catalyst Investors.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Pamela D Mcgarrah, MD Po Box 11407, Dept# 5839, Sheffield, AL 35660 Ph: (256) 381-6673 | Mrs Pamela D Mcgarrah, MD 1100 S Jackson Hwy Ste 250, Sheffield, AL 35660-5774 Ph: (256) 381-6673 |
News Archive
Taking turns gazing into a surgical microscope, 130 seventh- and eighth-graders from Los Angeles area schools will see a phantom skull and perform virtual surgery - and many could catch a glimpse of the future.
The Alzheimer's Drug Discovery Foundation (ADDF) announced today that it has awarded a grant of $240,000 to AgeneBio Inc. to develop a new class of small-molecules that have promise in treating amnestic mild cognitive impairment (aMCI), a neurological condition that often progresses to Alzheimer's disease and affects more than 3 million aging Americans.
"The number of Americans enrolled in high-deductible health plans has risen to more than 10 million but still represents a small portion of the insurance market, according to a report from insurance group America's Health Insurance Plans. Enrollments in these high-deductible health plans, which typically are paired with tax-free health savings accounts or health-reimbursement arrangements, are up about 25 percent from last year, the report said" (5/20).
The U.S. Food and Drug Administration today approved several strengths of potassium chloride oral solution as the first generic drugs to receive a Competitive Generic Therapy designation.
MINDBODY, Inc., the industry leader in cloud-based, business management software for health and wellness organizations worldwide, has received a major investment from two of the country's most respected venture capital firms, Bessemer Venture Partners and Catalyst Investors.
› Verified 8 days ago
Dr. Francis Allen Long Jr., MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 421 Cox Blvd, Sheffield, AL 35660 Phone: 256-386-7040 Fax: 256-383-7808 |